Metropolis Healthcare Limited (NSE: METROPOLIS)

Market Cap	94.65B
Revenue (ttm)	12.85B
Net Income (ttm)	1.48B
Shares Out	51.27M
EPS (ttm)	28.77
PE Ratio	64.16
Forward PE	47.30
Dividend	4.00 (0.22%)
Ex-Dividend Date	n/a

Volume	65,211
Average Volume	151,915
Open	1,889.90
Previous Close	1,895.55
Day's Range	1,834.20 - 1,910.25
52-Week Range	1,545.20 - 2,318.30
Beta	0.34
RSI	25.94
Earnings Date	Feb 7, 2025

About Metropolis Healthcare

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laborat...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1981
• Employees: 4,313
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: METROPOLIS

Financial Performance

In 2023, Metropolis Healthcare's revenue was 12.08 billion, an increase of 5.18% compared to the previous year's 11.48 billion. Earnings were 1.28 billion, a decrease of -10.54%.